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Abstract
Background: S100B protein and Neuron Specific Enolase (NSE) can increase due to brain cell damage
and/or increased permeability of the blood-brain-barrier. Elevation of these proteins has been shown after
various neurological diseases with cognitive dysfunction. Delirium is characterized by temporal cognitive
deficits and is an important risk factor for dementia. The aim of this study was to compare the level of
S100B and NSE of patients before, during and after delirium with patients without delirium and investigate
the possible associations with different subtypes of delirium.
Methods: The study population were patients aged 65 years or more acutely admitted after hip fracture.
Delirium was diagnosed by the Confusion Assessment Method and the subtype by Delirium Symptom
interview. In maximal four serum samples per patient S100B and NSE levels were determined by
electrochemiluminescence immunoassay.
Results: Of 120 included patients with mean age 83.9 years, 62 experienced delirium. Delirious patients
had more frequently pre-existing cognitive impairment (67% vs. 18%, p < 0.001). Comparing the first
samples during delirium to samples of non-delirious patients, a difference was observed in S100B (median
0.16 versus 0.10 μg/L, p = < 0.001), but not in NSE (median 11.7 versus 11.7 ng/L, p = 0.97). Delirious
state (before, during, after) (p < 0.001), day of blood withdrawal (p < 0.001), pre- or postoperative status
(p = 0.001) and type of fracture (p = 0.036) were all associated with S100B level. The highest S100B levels
were found 'during' delirium. S100B levels 'before' and 'after' delirium were still higher than those from
'non-delirious' patients. No significant difference in S100B (p = 0.43) or NSE levels (p = 0.41) was seen
between the hyperactive, hypoactive and mixed subtype of delirium.
Conclusion: Delirium was associated with increased level of S100B which could indicate cerebral damage
either due to delirium or leading to delirium. The possible association between higher levels of S100B
during delirium and the higher risk of developing dementia after delirium is an interesting field for future
research. More studies are needed to elucidate the role of S100B proteins in the pathophysiological
pathway leading to delirium and to investigate its possibility as biomarker for delirium.
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Background
Postoperative delirium following orthopedic surgery for
hip fracture occurs in up to 62% of the elderly patients,
many with pre-existing dementia[1]. It is characterized
by fluctuating changes in cognition, consciousness and
attention and lasts on average, three days[1,2]. Three
clinical subtypes of delirium are known; a hyperactive, a
hypoactive, and a mixed subtype [3,4]. So far, the sug-
gested pathophysiological mechanisms of delirium are
mostly hypothetical, but lately there is a lot of interest in
the neuroinflammatory system [5-7]. Although patients
usually recover after resolution of the underlying cause,
delirium appears to be an important risk factor for
dementia, even in people without prior cognitive
impairment[8].
The high frequency of dementia after delirium possibly
reflects irreversible brain damage caused by the detri-
mental effects of the pathophysiological mechanisms of
delirium on the brain. Moreover, it can be hypothesized
that postoperative delirium itself might be the conse-
quence of transient cerebral neuronal damage caused by
peri-operative hypoxia, micro embolisms[9] or hypoten-
sion[10].
S100B-protein (S100B) and Neuron Specific Enolase
(NSE) have been used as markers of brain damage in var-
ious diseases[11]. S100B belongs to the family of calcium
binding proteins, it is expressed mainly by astrocytes and
it is found in both intra- and extracellularly in brain tis-
sue[12]. S100B is usually elevated in blood and in CSF
due to nervous system damage, via functional disturbance
of membrane integrity and/or increased permeability of
the blood-brain barrier. NSE is the intracytoplasmic glyc-
olytic enzyme enolase. It is found in neurons and neuro-
endocrine tissue and it is elevated in the blood circulation
after increased death rate of these cells.
Elevated levels of S100B have been shown to be associ-
ated with delirium in patients after abdominal sur-
gery[13], after cardiac surgery[14] and in sepsis-
associated delirium[15]. NSE was not elevated in serum
in patients with delirium tremens[16] but it has been
found to correlate with the degree of cognitive dysfunc-
tion at discharge from hospital after cardiac surgery but
not after non-cardiac surgery[17,18]. In these previous
studies the delirious state at the day the sample was
taken was not taken into account, neither subtype. The
aim of this study in elderly hip fracture patients was two-
fold: (1) to compare changes before and after surgery of
S100B and NSE levels in serum in patients with and
without postoperative delirium, and to investigate the
difference in serum levels before, during and after delir-
ium; (2) to study the serum levels of S100B and NSE in
different subtypes of delirium.
Methods
Patients
From May 2005 through February 2008, all consecutive
patients 65 years of age or older who were acutely admit-
ted with hip fracture to the Academic Medical Centre,
Amsterdam were invited to participate. Informed consent
was obtained from all patients or from substitute deci-
sion-makers in cases of cognitive impairment. Patients
were excluded if they were not scheduled for operation or
were unable to speak or understand Dutch or English. The
institutional Medical Ethics Committee approved the
study.
Procedures
Members of the research team completed a multidiscipli-
nary evaluation for all study participants. Two geriatri-
cians, a fellow in geriatric medicine, and four research
nurses trained in geriatric medicine collected demo-
graphic and clinical data. The presence or absence of delir-
ium was scored during weekdays separately by a physician
and a nurse using the Confusion Assessment Method
(CAM) [19]. We based our information for the diagnosis
on our psychiatric examination of the patient, medical
and nursing records including the Delirium Observation
Screening Scale (DOS) [20], and information given by the
patient's closest relative. When the diagnosis of delirium
was doubtful, the patient was discussed in the geriatric
consultation team to gain consensus. To identify the sub-
type of delirium we used the Delirium Symptom Inter-
view with the cut-off scores described by Liptzin et al This
resulted in three different subtypes: the hyperactive,
hypoactive and mixed subtype[21]. The Delirium Rating
Scale-Revised-98 (DRS-R-98) was used to monitor the
severity of delirium[22,23].
Possible confounding factors, including demography,
fracture characteristics, type of anesthesia, type of surgery,
and peri- and postoperative complications were registered
for all patients. The number of medication taken at home
was taken as global measure of co-morbidity. Pre-existent
global cognitive functioning was based upon anamnesis,
medical history, and IQCODE-SF (Informant Question-
naire on COgnitive Decline-Short Form). The IQCODE-
SF assesses the possible presence of global cognitive
impairment based on the response of an informant who
had known the patient for at least ten years [24]. The
informant was asked to recall the situation two weeks
prior to the hip fracture and compare it with the situation
ten years earlier. Patients with a mean score of 3.9 or
higher were considered to have global cognitive impair-
ment [25]. To measure pre-existent physical functionality,
we asked patients, or their closest relative in cases of cog-
nitive impairment, to complete the 15-item Katz ADL
scale based on the situation two weeks prior to the hip
fracture[26].BMC Neurology 2009, 9:21 http://www.biomedcentral.com/1471-2377/9/21
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A maximum of four blood samples was collected during
the hospital stay under similar conditions around 11.00
am. Samples were taken during weekdays whenever
patients were available for venipuncture. Blood was kept
on ice after withdrawal. Serum was obtained by centrifu-
gation for 15 minutes at 1780 g at 4°C, and aliquots
were stored at -80°C. S-100B and NSE levels were meas-
ured on the Modular Analytics E170 (Elecsys module)
analyzer (Roche Diagnostics, Mannheim) using the elec-
trochemiluminescence immunoassays (ECLIA) tech-
nique. Normal values were established for S100B as
below 0.10 μg/l and for NSE as below 12.5[27,28]. NSE
will not be determined in case of even light hemolysis,
because hemolysis could substantially increase the NSE
value in serum due to the presence in erythrocytes[12].
Interleukin (IL) concentrations (IL-6 and IL-8) were
measured using a cytometric bead array (CBA) immu-
noassay (BD Biosciences Pharmingen, San Diego, CA).
The chemical analysts were blinded to the clinical diag-
nosis of the patients.
Statistical Analysis
Statistical Package for the Social Sciences (SPSS) version
15.0 was used for data analysis. We tested for differences
in characteristics in patients with and without delirium
using T-tests and Mann-Whitney Tests. Variables that were
not normally distributed were expressed as median scores
and inter-quartile ranges. Differences in NSE levels in dif-
ferent subtypes were analyzed using ANOVA and in
S100B levels using the Kruskal-Wallis test. A two-tailed
criterion of p < 0.05 was considered statistically signifi-
cant. Correlations between NSE and DRS-R-98 score,
between S100B and DRS-R-98 score, and between S100B
and NSE with IL-6 as well as IL-8 were determined using
Spearman's rho test.
To examine the association of S100B with delirium state
we used the linear mixed models approach. For S100B
level the e-based log transformation was used, patient
number was taken as a random effect, and day of sam-
pling, delirious state, and the interaction between these
two variables were taken as fixed effects. The association
between NSE and delirium was analyzed in a similar way
'Delirious state' consisted of four categories based on the
CAM scores of the patient at the moment the sample was
taken: samples from patients in the non-delirious group
were all categorized (1)'non-delirious', samples from
patients in the delirious group were categorized (2)'before
delirium', (3)'during delirium' or (4)'after delirium'. In
addition, pre- or postoperative status, type of fracture,
type of surgery, type of anesthesia, global cognitive
impairment, and age were considered as covariates in the
mixed model. In a backward selection procedure within
the linear mixed models all variables with p-value above
0.05 were removed. The goodness of fit of the mixed mod-
els was inspected by assessing the distribution of the resid-
uals.
Results
During the inclusion period 271 patients aged 65 years
and older were admitted. A total of 55 patients were
excluded due to lack of informed consent, 63 patients did
not consent to extra blood withdrawal and 33 patients
were excluded for logistic reasons. In and excluded
patients were similar with regard to the male/female ratio,
but the excluded patients were younger (mean age of 81.3
years versus 83.9 years, p = 0.005). In total 120 patients
were included, 62 (52%) with delirium and 58 without.
This resulted in 387 samples in total, 196 samples of delir-
ious patients (21 samples taken before the delirious epi-
sode, 120 samples taken during the delirious episode, 55
taken after the delirious episode) and 191 samples of
patients without delirium.
Patients with delirium experienced significantly more
often pre-existent cognitive and functional impairment (p
< 0.001) and lived in either old-people's homes or nursing
homes significantly more frequently than non-delirious
controls (p < 0.001) (Table 1). There was no significant
difference in the type of anesthesia (p = 0.35), type of sur-
gery (p = 0.54) or total number of complications (p =
0.19) between patients with and without delirium. The
median time of admission was 14 days for patients with
delirium and 11 days for patients without delirium (p =
0.04).
Table 2 describes the levels of S100B and NSE in the first
sample during the delirious episode in the delirious group
compared to samples withdrawn at a comparable day
before or after surgery of the non-delirious group (mean
postoperative day 1.3, SD: 1.6). More delirious (81%)
than non-delirious (50%) patients had levels above the
normal values of S100B (p = 0.001). Also, the levels of
S100B were higher in delirious patients (0.16 μg/L) com-
pared to the non-delirious patients (0.10 μg/L) (p <
0.001). In our samples NSE was not determined in 153
(38%) of the samples, because of hemolysis due the pres-
ervation of the samples on ice after withdrawal. The NSE
level was 11.7 (ng/L) both in cases and controls (p =
0.97). There was no significant correlation with S100B
and NSE levels length of admission, death within the first
3 month or preoperative cognitive impairment. No corre-
lation between NSE levels and IL-6 or IL-8 was observed,
but significant correlation was found between levels of
S100B and Il-6 (r = 0.35, p < 0.001) or IL-8 (r = 0.36, p <
0.001).
To study the course over time of S100B, we included sam-
ples from the day before surgery until post-operative day
eight because during this period samples from both deliri-BMC Neurology 2009, 9:21 http://www.biomedcentral.com/1471-2377/9/21
Page 4 of 7
(page number not for citation purposes)
ous and non-delirious patients were available. Following a
backward approach, type of surgery, type of anesthesia, glo-
bal cognitive impairment, and age were removed. The final
statistical model included delirious state (p < 0.001), day of
blood withdrawal (p < 0.001), pre- or postoperative status
(p = 0.001) and type of fracture (p = 0.036). To illustrate
the effect of delirium on S100B, levels of three different
example patients with an intertrochanteric hip fracture
were calculated and are presented in figure 1: 1) a patient
who was delirious from one day before operation until
eight days after operation (continuously delirious), 2) a
patient who was never delirious during this period (contin-
uously non-delirious), and 3) a patient who was delirious
from the day after operation until postoperative day four
(delirious day 1–4). S100B levels were highest 'during'
delirium at all time-points. 'Before' and 'after' delirium
S100B levels were still higher than those from 'non-deliri-
ous' patients. Delirious state was not significant in the same
mixed model analysis with NSE in 233 samples. Spear-
man's rho test showed no significant correlation between
S100B and NSE levels in the first sample (p = 0.99).
In 34 delirious patients, delirium subtype was specified;
one patient did not meet the criteria for any of the sub-
types (Table 3). Specification of the subtype was missing
for 23 delirious patients and from five patients no blood
sample was taken during delirium. Delirious patients with
known subtype were similar to delirious patients with
unknown subtype with respect to age, sex and cognitive
impairment, day of blood withdrawal, pre- or postopera-
tive status and type of fracture. No large difference was
observed in NSE and S100B levels in patients with differ-
ent subtypes, nor was there a difference in levels between
patients with known vs. unknown subtype. Of 38 patients
the severity of delirium (DRS-R-98) was specified. Spear-
man's test revealed no significant correlation between lev-
els of DRS-R-98 and NSE (r = 0.20, p = 0.32) or S100B (r
= -0.08, p = 0.62).
Discussion
This study among elderly patients admitted for hip frac-
ture showed that delirium was associated with increased
Table 1: Characteristics of Patients With and Without Delirium.
Variables Delirium
(N = 62)
No delirium
(N = 58)
p-value
Age (yrs) 84.8 (6.9) 82.9 (7.0) 0.14
Male gender (%) 16 (26) 23 (40) 0.11
Living at home (%) 30 (48) 51 (88) < 0.001
Pre-admission functional impairment (number of ADL disabilities) 8 (6–11) 4 (2–6) < 0.001
Number of medication at home 5 (2–7) 4 (2–6) 0.18
Pre-admission cognitive impairment (%) 39 (67) 10 (18) < 0.001
Days between fracture and operation 1 (0–1) 1 (1–2) 0.49
Spinal anesthesia (%) 22 (36) 19 (33) 0.35
Fracture characteristics (%) 0.54
Femoral neck 25 (40) 28 (48)
Intertrochanteric 33 (53) 25 (43)
Other 4 (7) 5 (9)
Type of surgery (%) 0.64
Internal fixation 40 (65) 35 (60)
Hip replacement 22 (36) 23 (40)
Complication (%)-total 29 (50) 22 (38) 0.19
IL-6 (pg/ml)* 51 (28–88) 36 (14–58) 0.01
IL-8 (pg/ml)* 15 (7.9–37) 9.3 (4.6–17) 0.03
Admission length 14 (8–23) 11 (8–14) 0.04
Death within 3 month (%) 11 (18) 5 (9) 0.14
Mean values (SD) are given for continuous variables with a normal distribution,
Median values (inter-quartile ranges) are given for variables that are not normally distributed.
ADL: Activities of daily living;
*Values of 47 delirious patients during delirium vs. 48 patients without delirium.
Table 2: S100B (μg/L) and NSE (ng/mL) values during delirium 
versus no delirium.
During delirium
(N = 57*)
No delirium
(N = 58)
p-value
NSE – number 35 40
N (%) > 12.5 9 (26) 15 (38) 0.28
Mean (SD) 11.7 (3.8) 11.7 (4.7) 0.97
S100B – number 57 58
N (%) > 0.10 46 (81) 29 (50) 0.001
Median (IQR) 0.16 (0.10–0.25) 0.10 (0.08–0.15) < 0.001
*In the group with delirium samples were the first samples during the 
delirious episode; in the group without delirium, samples of 
comparable postoperative day were taken. Of five patients in the 
delirious group no sample taken during delirium.BMC Neurology 2009, 9:21 http://www.biomedcentral.com/1471-2377/9/21
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level of S100B which could indicate cerebral damage
either due to delirium or leading to delirium. The study
population represents a typical cross-section of elderly
patients admitted for hip fractures. A similar frequency of
delirium (52%) has been found in other large studies of
hip fracture patients[29]. The expected risk factors for
delirium in surgical patients, such as functional and cog-
nitive impairment, were confirmed in our study[30]. Next
to delirium, type of fracture, pre- or postoperative status
and day of blood withdrawal were all associated with
S100B levels. The effect of fracture and surgery and the
time course were expected covariables based on the litera-
ture[31]. Although the group of delirious patients with
known subtype was small, the hyperactive type of delir-
ium was the most common subtype of delirium in our
study, similar to what has been described by others[32].
Moreover, selection bias seems improbable since the
delirious patients included in this analysis did not differ
in associated factors with S100B and levels of NSE and
S100B compared to the delirious patients without known
Three representative patients with an intertrochanteric fracture to show the changes of S100B during admission calculated  with values of the mixed model analysis of all samples Figure 1
Three representative patients with an intertrochanteric fracture to show the changes of S100B during admis-
sion calculated with values of the mixed model analysis of all samples. The final model included delirious state (p < 
0.001), day of blood withdrawal (p < 0.001), pre- or postoperative status (p = 0.001) and type of fracture (p = 0.036). Postop-
erative day 0 is day of surgery.
Table 3: Values of NSE (ng/mL) and S100B (μg/L) and DRS-R-98 scores during delirium in different subtypes.*
Hyperactive Mixed Hypoactive p-value
NSE – number 11 8 4
N (%) > 12.5 4 (36) 4 (50) 1 (25) 0.68
Mean (SD) 12.2 (3.8) 14.3 (5.5) 11.0 (2.8) 0.41
S100B – number 17 12 4
N (%) > 0.10 13 (77) 11 (92) 3 (75) 0.54
Median (IQR) 0.17 (0.10–0.21) 0.23 (0.11–0.32) 0.12 (0.09–0.54) 0.43
DRS-R-98† 19 20 18 0.25
IQR: inter-quartile-range; DRS-R-98: Delirium Rating Scale-R-98.
*Subtype is specified in 34 delirious patients; one patient did not meet the criteria of any of the subtypes; specification of the subtype was missing 
for 23 delirious patients; of five patients no blood sample was taken during delirium.
†DRS-R-98 score is specified in 29 of the patients with known subtype.BMC Neurology 2009, 9:21 http://www.biomedcentral.com/1471-2377/9/21
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subtype. Because this still could have introduced a bias,
future studies are needed to confirm the lack of associa-
tion between subtypes and NSE or S100B.
A limitation of our study is that the NSE and S100B values
were measured from peripheral blood and may not neces-
sarily correspond to values in the brain. Under normal
conditions serum NSE and NSE in cerebrospinal fluid
(CSF) show no significant correlation, whereas serum
S100B content is lower than that in CSF[11,33]. We are
not aware of studies that determined NSE and S100B in
both CSF and blood among patients with cognitive defi-
cits such as delirium. A second limitation of our study is
that only 120 of the 183 (66%) patients consented to
multiple blood withdrawals. Although the excluded
patients were 2.5 yrs. younger it is unlikely that this small
difference would affect the protein levels.
Our results showing elevated S100B levels in delirious
patients are in line with former studies [13-15]. Studies
looking at postoperative cognitive deficit (POCD) and
S100B after surgery show however contradicting results,
with no relation between S100B and cognitive perform-
ance after cardiac surgery at discharge [17], a questionable
relation directly after cardiac surgery [34], but higher lev-
els of S100B in patients with POCD after non-cardiac sur-
gery[18]. The definition of POCD remains controversial,
but it seems likely that delirium and short-term POCD are
on a continuum of postoperative cognitive brain disor-
ders[35]. Seeing delirium as subset of POCD, our results
of NSE correspond to former studies that found no asso-
ciation between NSE and POCD at discharge from hospi-
tal after non-cardiac surgery[18]. Maybe NSE is released
only in cases of severe brain damage, such as stroke, after
resuscitation or neurologically complicated surgery[18].
Importantly, S100B is a marker of cerebral damage and/or
reduced integrity of the blood brain barrier. In stroke, glo-
bal hypoxia and traumatic brain injury a positive correla-
tion between S100B and cognitive outcome has been
established [36]. Possibly, the high frequency of dementia
after delirium could also be predicted by the level of
S100B during delirium. Predictive factors for cognitive
outcome after delirium are unknown, largely because of
the difficulties of diagnosing pre-existent cognitive func-
tioning in patients with delirium[5]. On the one hand
delirium and dementia (or cognitive impairment) could
each be caused by the same precipitating factors such as
the surgical procedure[7]. On the other hand, it could be
hypothesized that dementia is caused by the detrimental
effects of delirium itself [5]. The neuroinflammatory sys-
tem seems to be a rational pathophysiological pathway
for delirium [5-7] and this same system has been
described in relation to cerebral damage [11]. The correla-
tion between the levels of S100B and the proinflamma-
tory cytokines IL6 and IL8 in the patients in this study can
be seen as an indication that the neuroinflammatory sys-
tem is related to possible cerebral damage due to delir-
ium.
Conclusion
In our study of elderly patients admitted for acute surgical
repair of hip fracture we found higher S100B levels in
patients with delirium than in patients without delirium
with the highest levels of S100B during delirium,. No dif-
ference in S100B and NSE levels between the different
subtypes of delirium was found. Future studies are needed
to elucidate the place of S100B in the pathophysiological
pathway leading to delirium (and possibly dementia) and
investigate its role as biomarker for delirium.
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